| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 2OP4E0GC6V |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | HLA-DR antigens-associated invariant chain antagonist | PubMed |
| Primary Target | |
|---|---|
| CD74 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Plasmacytoma | 1 | D010954 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 899796-83-9 |
| ChEMBL | CHEMBL1743040 |
| FDA SRS | 2OP4E0GC6V |
| Guide to Pharmacology | 8267 |
CONTENTS